SubmitCancel

Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

P05556

- ITB1_HUMAN

UniProt

P05556 - ITB1_HUMAN

(max 400 entries)x

Your basket is currently empty.

Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)

Protein

Integrin beta-1

Gene
ITGB1, FNRB, MDF2, MSK12
Organism
Homo sapiens (Human)
Status
Reviewed - Annotation score: 5 out of 5 - Experimental evidence at protein leveli

Functioni

Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1, alpha-3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-10/beta-1, alpha-11/beta-1 and alpha-V/beta-1 are receptors for fibronectin. Alpha-4/beta-1 recognizes one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. Integrin alpha-5/beta-1 is a receptor for fibrinogen. Integrin alpha-1/beta-1, alpha-2/beta-1, alpha-6/beta-1 and alpha-7/beta-1 are receptors for lamimin. Integrin alpha-4/beta-1 is a receptor for VCAM1. It recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-9/beta-1 is a receptor for VCAM1, cytotactin and osteopontin. It recognizes the sequence A-E-I-D-G-I-E-L in cytotactin. Integrin alpha-3/beta-1 is a receptor for epiligrin, thrombospondin and CSPG4. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration. Integrin alpha-V/beta-1 is a receptor for vitronectin. Beta-1 integrins recognize the sequence R-G-D in a wide array of ligands. Isoform 2 interferes with isoform 1 resulting in a dominant negative effect on cell adhesion and migration (in vitro). In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. When associated with alpha-7/beta-1 integrin, regulates cell adhesion and laminin matrix deposition. Involved in promoting endothelial cell motility and angiogenesis. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process and the formation of mineralized bone nodules. May be involved in up-regulation of the activity of kinases such as PKC via binding to KRT1. Together with KRT1 and GNB2L1/RACK1, serves as a platform for SRC activation or inactivation. Plays a mechanistic adhesive role during telophase, required for the successful completion of cytokinesis.7 Publications
Isoform 5: Isoform 5 displaces isoform 1 in striated muscles By similarity.7 Publications

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Metal bindingi152 – 1521Magnesium
Metal bindingi154 – 1541Calcium 1; via carbonyl oxygen
Metal bindingi156 – 1561Calcium 1
Metal bindingi157 – 1571Calcium 1
Metal bindingi189 – 1891Calcium 2
Metal bindingi244 – 2441Calcium 2
Metal bindingi246 – 2461Calcium 2
Metal bindingi248 – 2481Calcium 2; via carbonyl oxygen
Metal bindingi249 – 2491Calcium 2
Metal bindingi249 – 2491Magnesium
Metal bindingi362 – 3621Calcium 1; via carbonyl oxygen

GO - Molecular functioni

  1. actin binding Source: BHF-UCL
  2. cell adhesion molecule binding Source: UniProtKB
  3. metal ion binding Source: UniProtKB-KW
  4. peptide binding Source: Ensembl
  5. protein binding Source: IntAct
  6. protein heterodimerization activity Source: UniProtKB
  7. virus receptor activity Source: UniProtKB-KW

GO - Biological processi

  1. axon guidance Source: Reactome
  2. B cell differentiation Source: BHF-UCL
  3. blood coagulation Source: Reactome
  4. calcium-independent cell-matrix adhesion Source: MGI
  5. cardiac muscle cell differentiation Source: Ensembl
  6. cell-cell adhesion mediated by integrin Source: BHF-UCL
  7. cell fate specification Source: Ensembl
  8. cell junction assembly Source: Reactome
  9. cell-matrix adhesion Source: BHF-UCL
  10. cell migration Source: HGNC
  11. cell migration involved in sprouting angiogenesis Source: Ensembl
  12. cellular calcium ion homeostasis Source: Ensembl
  13. cellular defense response Source: ProtInc
  14. cellular response to ionizing radiation Source: Ensembl
  15. cellular response to mechanical stimulus Source: Ensembl
  16. cellular response to vitamin D Source: Ensembl
  17. extracellular matrix organization Source: Reactome
  18. formation of radial glial scaffolds Source: Ensembl
  19. G1/S transition of mitotic cell cycle Source: Ensembl
  20. germ cell migration Source: Ensembl
  21. homophilic cell adhesion Source: ProtInc
  22. integrin-mediated signaling pathway Source: UniProtKB-KW
  23. in utero embryonic development Source: Ensembl
  24. leukocyte cell-cell adhesion Source: BHF-UCL
  25. leukocyte migration Source: Reactome
  26. maternal process involved in female pregnancy Source: Ensembl
  27. negative regulation of anoikis Source: UniProtKB
  28. negative regulation of cell projection organization Source: Ensembl
  29. negative regulation of cell proliferation Source: Ensembl
  30. negative regulation of neuron differentiation Source: Ensembl
  31. positive regulation of apoptotic process Source: MGI
  32. positive regulation of cell migration Source: Ensembl
  33. positive regulation of cell proliferation Source: Ensembl
  34. positive regulation of cell-substrate adhesion Source: Ensembl
  35. positive regulation of endocytosis Source: Ensembl
  36. positive regulation of MAPK cascade Source: Ensembl
  37. positive regulation of neuron differentiation Source: Ensembl
  38. positive regulation of neuron projection development Source: Ensembl
  39. positive regulation of peptidyl-tyrosine phosphorylation Source: Ensembl
  40. protein transport within lipid bilayer Source: Ensembl
  41. regulation of cell cycle Source: Ensembl
  42. regulation of G-protein coupled receptor protein signaling pathway Source: Ensembl
  43. regulation of immune response Source: Reactome
  44. response to activity Source: Ensembl
  45. response to drug Source: Ensembl
  46. response to gonadotropin Source: Ensembl
  47. response to transforming growth factor beta Source: Ensembl
  48. sarcomere organization Source: Ensembl
  49. tight junction assembly Source: Ensembl
  50. tissue homeostasis Source: Ensembl
  51. viral process Source: UniProtKB-KW
Complete GO annotation...

Keywords - Molecular functioni

Host cell receptor for virus entry, Integrin, Receptor

Keywords - Biological processi

Cell adhesion, Host-virus interaction

Keywords - Ligandi

Calcium, Magnesium, Metal-binding

Enzyme and pathway databases

ReactomeiREACT_11152. Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
REACT_12051. Cell surface interactions at the vascular wall.
REACT_1230. Platelet Adhesion to exposed collagen.
REACT_12560. Basigin interactions.
REACT_13552. Integrin cell surface interactions.
REACT_150331. Molecules associated with elastic fibres.
REACT_150366. Elastic fibre formation.
REACT_160131. Fibronectin matrix formation.
REACT_163906. ECM proteoglycans.
REACT_163942. Syndecan interactions.
REACT_169262. Laminin interactions.
REACT_19200. Other semaphorin interactions.
REACT_20617. Localization of the PINCH-ILK-PARVIN complex to focal adhesions.
REACT_22272. Signal transduction by L1.
REACT_22292. CHL1 interactions.
SABIO-RKP05556.
SignaLinkiP05556.

Names & Taxonomyi

Protein namesi
Recommended name:
Integrin beta-1
Alternative name(s):
Fibronectin receptor subunit beta
Glycoprotein IIa
Short name:
GPIIA
VLA-4 subunit beta
CD_antigen: CD29
Gene namesi
Name:ITGB1
Synonyms:FNRB, MDF2, MSK12
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
ProteomesiUP000005640: Chromosome 10

Organism-specific databases

HGNCiHGNC:6153. ITGB1.

Subcellular locationi

Cell membrane; Single-pass type I membrane protein. Recycling endosome. Melanosome. Cleavage furrow. Cell projectionlamellipodium. Cell projectionruffle
Note: Isoform 2 does not localize to focal adhesions. Highly enriched in stage I melanosomes. Located on plasma membrane of neuroblastoma NMB7 cells. In a lung cancer cell line, in prometaphase and metaphase, localizes diffusely at the membrane and in a few intracellular vesicles. In early telophase, detected mainly on the matrix-facing side of the cells. By mid-telophase, concentrated to the ingressing cleavage furrow, mainly to the basal side of the furrow. In late telophase, concentrated to the extending protrusions formed at the opposite ends of the spreading daughter cells, in vesicles at the base of the lamellipodia formed by the separating daughter cells. Colocalizes with ITGB1BP1 and metastatic suppressor protein NME2 at the edge or peripheral ruffles and lamellipodia during the early stages of cell spreading on fibronectin or collagen. Translocates from peripheral focal adhesions sites to fibrillar adhesions in a ITGB1BP1-dependent manner.9 Publications
Isoform 5 : Cell membranesarcolemma By similarity. Cell junction By similarity
Note: In cardiac muscle, isoform 5 is found in costameres and intercalated disks By similarity.9 Publications

Topology

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Topological domaini21 – 728708Extracellular Reviewed predictionAdd
BLAST
Transmembranei729 – 75123Helical; Reviewed predictionAdd
BLAST
Topological domaini752 – 79847Cytoplasmic Reviewed predictionAdd
BLAST

GO - Cellular componenti

  1. acrosomal vesicle Source: Ensembl
  2. basement membrane Source: Ensembl
  3. cell surface Source: BHF-UCL
  4. cleavage furrow Source: UniProtKB-SubCell
  5. cytoplasm Source: BHF-UCL
  6. external side of plasma membrane Source: Ensembl
  7. extracellular vesicular exosome Source: UniProt
  8. filopodium Source: BHF-UCL
  9. focal adhesion Source: MGI
  10. hemidesmosome Source: Ensembl
  11. integrin alpha3-beta1 complex Source: Ensembl
  12. integrin alpha7-beta1 complex Source: Ensembl
  13. integrin alpha8-beta1 complex Source: BHF-UCL
  14. integrin alpha9-beta1 complex Source: Ensembl
  15. integrin complex Source: UniProtKB
  16. intercalated disc Source: Ensembl
  17. lamellipodium Source: UniProtKB-SubCell
  18. melanosome Source: UniProtKB-SubCell
  19. membrane raft Source: BHF-UCL
  20. myelin sheath abaxonal region Source: Ensembl
  21. neuromuscular junction Source: MGI
  22. plasma membrane Source: UniProtKB
  23. receptor complex Source: MGI
  24. recycling endosome Source: UniProtKB-SubCell
  25. ruffle Source: HGNC
  26. sarcolemma Source: MGI
Complete GO annotation...

Keywords - Cellular componenti

Cell junction, Cell membrane, Cell projection, Endosome, Membrane

Pathology & Biotechi

Mutagenesis

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Mutagenesisi760 – 7612RR → AA: No effect on interaction with ACAP1.
Mutagenesisi762 – 7676EFAKFE → AAAAAA: Strongly reduces interaction with ACAP1 and ability to recycle; does not affect heterodimerization with ITGA5. 1 Publication
Mutagenesisi762 – 7632EF → AA: Slightly reduces interaction with ACAP1.
Mutagenesisi765 – 7651K → A: Reduces interaction with ACAP1.
Mutagenesisi766 – 7672FE → AA: Slightly reduces interaction with ACAP1.
Mutagenesisi768 – 7692KE → AA: No effect on interaction with ACAP1.
Mutagenesisi778 – 7781G → Q: Loss of beta-1A interaction with FLNA and FLNB. 1 Publication
Mutagenesisi786 – 7916AVTTVV → PINNFK: Does not interact with ITGB1BP1. 2 Publications
Mutagenesisi786 – 7861A → P: Loss of beta-1A interaction with FLNA and FLNB. 1 Publication
Mutagenesisi787 – 7871V → T: Reduces interaction with ITGB1BP1, but not with FERMT2 or TLN1. Inhibits fibronectin deposition and mineralized bone nodules formation. 1 Publication
Mutagenesisi788 – 7881T → D: Strongly reduces ITGB1BP1 binding; when associated with D-790. 1 Publication
Mutagenesisi790 – 7901V → D: Strongly reduces ITGB1BP1 binding; when associated with D-788. 1 Publication
Mutagenesisi792 – 7921N → A: Strongly reduces ITGB1BP1 binding; when associated with A-795. 1 Publication
Mutagenesisi795 – 7951Y → A: Strongly reduces ITGB1BP1 binding; when associated with A-792. 1 Publication

Organism-specific databases

PharmGKBiPA29953.

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Signal peptidei1 – 2020Add
BLAST
Chaini21 – 798778Integrin beta-1PRO_0000016334Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Disulfide bondi27 ↔ 451 Publication
Disulfide bondi35 ↔ 4641 Publication
Disulfide bondi38 ↔ 641 Publication
Disulfide bondi48 ↔ 751 Publication
Glycosylationi50 – 501N-linked (GlcNAc...) Reviewed prediction
Glycosylationi94 – 941N-linked (GlcNAc...) Reviewed prediction
Glycosylationi97 – 971N-linked (GlcNAc...) Reviewed prediction
Disulfide bondi207 ↔ 2131 Publication
Glycosylationi212 – 2121N-linked (GlcNAc...)1 Publication
Disulfide bondi261 ↔ 3011 Publication
Glycosylationi269 – 2691N-linked (GlcNAc...)1 Publication
Glycosylationi363 – 3631N-linked (GlcNAc...) Reviewed prediction
Disulfide bondi401 ↔ 4151 Publication
Glycosylationi403 – 4031N-linked (GlcNAc...); atypical1 Publication
Glycosylationi406 – 4061N-linked (GlcNAc...)3 Publications
Glycosylationi411 – 4111N-linked (GlcNAc...); atypical1 Publication
Glycosylationi417 – 4171N-linked (GlcNAc...) Reviewed prediction
Disulfide bondi435 ↔ 4621 Publication
Disulfide bondi466 ↔ 691 Inferred
Disulfide bondi477 ↔ 489 By similarity
Glycosylationi481 – 4811N-linked (GlcNAc...)1 Publication
Disulfide bondi486 ↔ 525 By similarity
Disulfide bondi491 ↔ 500 By similarity
Disulfide bondi502 ↔ 516 By similarity
Glycosylationi520 – 5201N-linked (GlcNAc...) Reviewed prediction
Disulfide bondi531 ↔ 536 By similarity
Disulfide bondi533 ↔ 568 By similarity
Disulfide bondi538 ↔ 553 By similarity
Disulfide bondi555 ↔ 560 By similarity
Disulfide bondi574 ↔ 579 By similarity
Disulfide bondi576 ↔ 607 By similarity
Disulfide bondi581 ↔ 590 By similarity
Glycosylationi584 – 5841N-linked (GlcNAc...) Reviewed prediction
Disulfide bondi592 ↔ 599 By similarity
Disulfide bondi613 ↔ 618 By similarity
Disulfide bondi615 ↔ 661 By similarity
Disulfide bondi620 ↔ 630 By similarity
Disulfide bondi633 ↔ 636 By similarity
Disulfide bondi640 ↔ 649 By similarity
Disulfide bondi646 ↔ 723 By similarity
Disulfide bondi665 ↔ 699 By similarity
Glycosylationi669 – 6691N-linked (GlcNAc...)1 Publication
Modified residuei777 – 7771Phosphothreonine1 Publication
Modified residuei783 – 7831Phosphotyrosine By similarity
Modified residuei794 – 7941N6-acetyllysine1 Publication

Post-translational modificationi

The cysteine residues are involved in intrachain disulfide bonds By similarity.

Keywords - PTMi

Acetylation, Disulfide bond, Glycoprotein, Phosphoprotein

Proteomic databases

MaxQBiP05556.
PaxDbiP05556.
PRIDEiP05556.

PTM databases

PhosphoSiteiP05556.

Miscellaneous databases

PMAP-CutDBQ8WUM6.

Expressioni

Tissue specificityi

Isoform 1 is widely expressed, other isoforms are generally coexpressed with a more restricted distribution. Isoform 2 is expressed in skin, liver, skeletal muscle, cardiac muscle, placenta, umbilical vein endothelial cells, neuroblastoma cells, lymphoma cells, hepatoma cells and astrocytoma cells. Isoform 3 and isoform 4 are expressed in muscle, kidney, liver, placenta, cervical epithelium, umbilical vein endothelial cells, fibroblast cells, embryonal kidney cells, platelets and several blood cell lines. Isoform 4, rather than isoform 3, is selectively expressed in peripheral T-cells. Isoform 3 is expressed in non-proliferating and differentiated prostate gland epithelial cells and in platelets, on the surface of erythroleukemia cells and in various hematopoietic cell lines. Isoform 5 is expressed specifically in striated muscle (skeletal and cardiac muscle).6 Publications

Gene expression databases

ArrayExpressiP05556.
BgeeiP05556.
GenevestigatoriP05556.

Organism-specific databases

HPAiCAB003434.

Interactioni

Subunit structurei

Heterodimer of an alpha and a beta subunit. Beta-1 associates with either alpha-1, alpha-2, alpha-3, alpha-4, alpha-5, alpha-6, alpha-7, alpha-8, alpha-9, alpha-10, alpha-11 or alpha-V. Binds LGALS3BP and NMRK2, when associated with alpha-7, but not with alpha-5. Interacts with FGR and HCK. Interacts (via the cytoplasmic region) with RAB25 (via the hypervariable C-terminal region). Interacts with RAB21. Interacts with KRT1 in the presence of GNB2L1 and SRC. Interacts with AMICA1; integrin alpha-4/beta-1 may regulate leukocyte to endothelial cells adhesion by controlling AMICA1 homodimerization. Interacts with HIV-1 Tat. Binds to human echoviruses 1 and 8 capsid proteins and acts as a receptor for these viruses. Interacts with FLNA, FLNB and RANBP9. Isoform 5 interacts with ACE2. Isoform 1 interacts with the C-terminal region of FLNC. Interacts with MYO10. Interacts with DAB2. Interacts with FERMT2; the interaction is inhibited in presence of ITGB1BP1. Interacts with ITGB1BP1 (via C-terminal region); the interaction is a prerequisite for focal adhesion disassembly. Interacts with TLN1; the interaction is prevented by competitive binding of ITGB1BP1. Interacts with human cytomegalovirus/HHV-5 envelope glycoprotein B/gB. Interacts with ACAP1; required for ITGB1 recycling. Interacts with ASAP3. Isoform 5 interacts with alpha-7A and alpha-7B in adult skeletal muscle. Isoform 5 interacts with alpha-7B in cardiomyocytes of adult heart.25 Publications

Binary interactionsi

WithEntry#Exp.IntActNotes
ANGPTL4Q9BY762EBI-703066,EBI-2968146
BMRF2P031922EBI-703066,EBI-9348955From a different organism.
CSF2RBP329275EBI-703066,EBI-1809771
ENGP178133EBI-703066,EBI-2834630
FABP3P054132EBI-703066,EBI-704216
FLNAP213335EBI-703066,EBI-350432
ITGA2P173013EBI-703066,EBI-702960
ITGA4P136123EBI-703066,EBI-703044
LYNP079484EBI-703066,EBI-79452
PTPN1P180312EBI-703066,EBI-968788
PXNP490232EBI-6082935,EBI-702209
Rab21P352823EBI-703066,EBI-1993555From a different organism.
TLN1Q9Y4902EBI-703066,EBI-2462036

Protein-protein interaction databases

BioGridi109894. 65 interactions.
DIPiDIP-312N.
IntActiP05556. 39 interactions.
MINTiMINT-140089.

Structurei

Secondary structure

1
798
Legend: HelixTurnBeta strand
Show more details
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Turni36 – 383
Beta strandi39 – 413
Helixi67 – 704
Turni71 – 744
Turni77 – 793
Beta strandi86 – 916
Turni108 – 1103
Beta strandi118 – 1236
Beta strandi131 – 1366
Beta strandi143 – 1508
Helixi153 – 1553
Helixi156 – 1627
Helixi165 – 1739
Turni174 – 1763
Beta strandi178 – 18710
Turni193 – 1953
Turni200 – 2045
Beta strandi209 – 2113
Beta strandi218 – 22710
Helixi229 – 2368
Beta strandi245 – 2495
Helixi251 – 26010
Helixi262 – 2654
Beta strandi269 – 28012
Turni285 – 2884
Helixi289 – 2913
Turni311 – 3133
Helixi319 – 32810
Beta strandi331 – 3388
Helixi339 – 3413
Helixi342 – 35110
Beta strandi355 – 3606
Helixi367 – 37913
Beta strandi382 – 3865
Beta strandi393 – 4008
Helixi402 – 4043
Beta strandi406 – 4083
Helixi409 – 4135
Beta strandi423 – 43412
Beta strandi438 – 44710
Beta strandi454 – 4607
Helixi752 – 76918
Helixi770 – 7723

3D structure databases

Select the link destinations:
PDBe
RCSB PDB
PDBj
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
1K11model-B786-797[»]
1LHAmodel-A86-543[»]
3G9WX-ray2.16C/D752-785[»]
3T9KX-ray2.30A/B758-769[»]
3VI3X-ray2.90B/D21-465[»]
3VI4X-ray2.90B/D21-465[»]
4DX9X-ray3.006/7/8/9/B/D/F/H/J/L/N/P/R/T/V/X/Z/b/d/f/h/j/l/n/p/r/t/v/x/z784-798[»]
ProteinModelPortaliP05556.
SMRiP05556. Positions 25-787.

Miscellaneous databases

EvolutionaryTraceiP05556.

Family & Domainsi

Domains and Repeats

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Domaini140 – 378239VWFAAdd
BLAST
Repeati466 – 51550IAdd
BLAST
Repeati516 – 55944IIAdd
BLAST
Repeati560 – 59839IIIAdd
BLAST
Repeati599 – 63537IVAdd
BLAST

Region

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Regioni466 – 635170Cysteine-rich tandem repeatsAdd
BLAST
Regioni762 – 7676Signal for sorting from recycling endosomes; interaction with ACAP1
Regioni785 – 7928Interaction with ITGB1BP1

Sequence similaritiesi

Contains 1 VWFA domain.

Keywords - Domaini

Repeat, Signal, Transmembrane, Transmembrane helix

Phylogenomic databases

eggNOGiNOG287997.
HOVERGENiHBG006190.
KOiK05719.
OMAiENNVYTM.
OrthoDBiEOG7T7GSB.
PhylomeDBiP05556.
TreeFamiTF105392.

Family and domain databases

Gene3Di1.20.5.630. 1 hit.
3.40.50.410. 1 hit.
InterProiIPR013111. EGF_extracell.
IPR027071. Integrin_beta-1.
IPR015812. Integrin_bsu.
IPR014836. Integrin_bsu_cyt_dom.
IPR002369. Integrin_bsu_N.
IPR012896. Integrin_bsu_tail.
IPR016201. Plexin-like_fold.
IPR002035. VWF_A.
[Graphical view]
PANTHERiPTHR10082. PTHR10082. 1 hit.
PTHR10082:SF28. PTHR10082:SF28. 1 hit.
PfamiPF07974. EGF_2. 1 hit.
PF08725. Integrin_b_cyt. 1 hit.
PF07965. Integrin_B_tail. 1 hit.
PF00362. Integrin_beta. 1 hit.
[Graphical view]
PIRSFiPIRSF002512. Integrin_B. 1 hit.
PRINTSiPR01186. INTEGRINB.
SMARTiSM00187. INB. 1 hit.
SM00423. PSI. 1 hit.
SM00327. VWA. 1 hit.
[Graphical view]
SUPFAMiSSF103575. SSF103575. 1 hit.
SSF53300. SSF53300. 1 hit.
SSF69687. SSF69687. 1 hit.
PROSITEiPS00022. EGF_1. 2 hits.
PS00243. INTEGRIN_BETA. 3 hits.
[Graphical view]

Sequences (5)i

Sequence statusi: Complete.

Sequence processingi: The displayed sequence is further processed into a mature form.

This entry describes 5 isoformsi produced by alternative splicing. Align

Isoform 1 (identifier: P05556-1) [UniParc]FASTAAdd to Basket

Also known as: Beta-1A

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

« Hide

MNLQPIFWIG LISSVCCVFA QTDENRCLKA NAKSCGECIQ AGPNCGWCTN    50
STFLQEGMPT SARCDDLEAL KKKGCPPDDI ENPRGSKDIK KNKNVTNRSK 100
GTAEKLKPED ITQIQPQQLV LRLRSGEPQT FTLKFKRAED YPIDLYYLMD 150
LSYSMKDDLE NVKSLGTDLM NEMRRITSDF RIGFGSFVEK TVMPYISTTP 200
AKLRNPCTSE QNCTSPFSYK NVLSLTNKGE VFNELVGKQR ISGNLDSPEG 250
GFDAIMQVAV CGSLIGWRNV TRLLVFSTDA GFHFAGDGKL GGIVLPNDGQ 300
CHLENNMYTM SHYYDYPSIA HLVQKLSENN IQTIFAVTEE FQPVYKELKN 350
LIPKSAVGTL SANSSNVIQL IIDAYNSLSS EVILENGKLS EGVTISYKSY 400
CKNGVNGTGE NGRKCSNISI GDEVQFEISI TSNKCPKKDS DSFKIRPLGF 450
TEEVEVILQY ICECECQSEG IPESPKCHEG NGTFECGACR CNEGRVGRHC 500
ECSTDEVNSE DMDAYCRKEN SSEICSNNGE CVCGQCVCRK RDNTNEIYSG 550
KFCECDNFNC DRSNGLICGG NGVCKCRVCE CNPNYTGSAC DCSLDTSTCE 600
ASNGQICNGR GICECGVCKC TDPKFQGQTC EMCQTCLGVC AEHKECVQCR 650
AFNKGEKKDT CTQECSYFNI TKVESRDKLP QPVQPDPVSH CKEKDVDDCW 700
FYFTYSVNGN NEVMVHVVEN PECPTGPDII PIVAGVVAGI VLIGLALLLI 750
WKLLMIIHDR REFAKFEKEK MNAKWDTGEN PIYKSAVTTV VNPKYEGK 798
Length:798
Mass (Da):88,415
Last modified:December 16, 2008 - v2
Checksum:iDE35979C1625578C
GO
Isoform 2 (identifier: P05556-2) [UniParc]FASTAAdd to Basket

Also known as: Beta-1B

The sequence of this isoform differs from the canonical sequence as follows:
     778-798: GENPIYKSAVTTVVNPKYEGK → VSYKTSKKQSGL

Show »
Length:789
Mass (Da):87,446
Checksum:i75834A92490CFBB0
GO
Isoform 3 (identifier: P05556-3) [UniParc]FASTAAdd to Basket

Also known as: Beta-1C

The sequence of this isoform differs from the canonical sequence as follows:
     778-798: GENPIYKSAVTTVVNPKYEGK → SLSVAQPGVQWCDISSLQPLTSRFQQFSCLSLPSTWDYRVKILFIRVP

Show »
Length:825
Mass (Da):91,620
Checksum:iD5DCB510A049FBEC
GO
Isoform 4 (identifier: P05556-4) [UniParc]FASTAAdd to Basket

Also known as: Beta-1C-2

The sequence of this isoform differs from the canonical sequence as follows:
     778-798: GENPIYKSAVTTVVNPKYEGK → PGVQWCDISSLQPLTSRFQQFSCLSLPSTWDYRVKILFIRVP

Show »
Length:819
Mass (Da):91,034
Checksum:i5838866B6DA6CECC
GO
Isoform 5 (identifier: P05556-5) [UniParc]FASTAAdd to Basket

Also known as: Beta-1D

The sequence of this isoform differs from the canonical sequence as follows:
     778-798: GENPIYKSAVTTVVNPKYEGK → QENPIYKSPINNFKNPNYGRKAGL

Show »
Length:801
Mass (Da):88,884
Checksum:i5A2DA413650A16BE
GO

Sequence cautioni

The sequence CAD97649.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened.

Alternative sequence

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Alternative sequencei778 – 79821GENPI…KYEGK → VSYKTSKKQSGL in isoform 2. VSP_002741Add
BLAST
Alternative sequencei778 – 79821GENPI…KYEGK → SLSVAQPGVQWCDISSLQPL TSRFQQFSCLSLPSTWDYRV KILFIRVP in isoform 3. VSP_002742Add
BLAST
Alternative sequencei778 – 79821GENPI…KYEGK → PGVQWCDISSLQPLTSRFQQ FSCLSLPSTWDYRVKILFIR VP in isoform 4. VSP_002743Add
BLAST
Alternative sequencei778 – 79821GENPI…KYEGK → QENPIYKSPINNFKNPNYGR KAGL in isoform 5. VSP_002744Add
BLAST

Sequence conflict

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sequence conflicti112 – 1121T → H in CAA30790. 1 Publication
Sequence conflicti215 – 2151S → T in CAA30790. 1 Publication
Sequence conflicti261 – 2655CGSLI → VWMLL in AAI13902. 1 Publication
Sequence conflicti385 – 3862EN → DG in AAI13902. 1 Publication
Sequence conflicti463 – 4631E → V in BAF84386. 1 Publication

Sequence databases

Select the link destinations:
EMBL
GenBank
DDBJ
Links Updated
X07979 mRNA. Translation: CAA30790.1.
AK291697 mRNA. Translation: BAF84386.1.
BX537407 mRNA. Translation: CAD97649.1. Different initiation.
AL365203 Genomic DNA. Translation: CAI14426.1.
CH471072 Genomic DNA. Translation: EAW85948.1.
CH471072 Genomic DNA. Translation: EAW85949.1.
CH471072 Genomic DNA. Translation: EAW85950.1.
CH471072 Genomic DNA. Translation: EAW85951.1.
CH471072 Genomic DNA. Translation: EAW85952.1.
CH471072 Genomic DNA. Translation: EAW85953.1.
CH471072 Genomic DNA. Translation: EAW85954.1.
CH471072 Genomic DNA. Translation: EAW85955.1.
CH471072 Genomic DNA. Translation: EAW85957.1.
CH471072 Genomic DNA. Translation: EAW85958.1.
CH471072 Genomic DNA. Translation: EAW85959.1.
BC020057 mRNA. Translation: AAH20057.1.
BC113901 mRNA. Translation: AAI13902.1.
U33879 Genomic DNA. Translation: AAA79832.1.
U33880, U33879 Genomic DNA. Translation: AAA79833.1.
U33882, U33879, U33881 Genomic DNA. Translation: AAA79834.1.
U33882, U33879 Genomic DNA. Translation: AAA79835.1.
M34189 mRNA. Translation: AAA59182.1.
M84237 mRNA. Translation: AAA74402.1.
M84237 mRNA. Translation: AAA74403.1.
U28252 mRNA. Translation: AAA81366.1.
CCDSiCCDS7174.1. [P05556-1]
PIRiB27079.
RefSeqiNP_002202.2. NM_002211.3. [P05556-1]
NP_391988.1. NM_033668.2. [P05556-5]
NP_596867.1. NM_133376.2. [P05556-1]
XP_005252505.1. XM_005252448.1. [P05556-5]
UniGeneiHs.643813.

Genome annotation databases

EnsembliENST00000302278; ENSP00000303351; ENSG00000150093. [P05556-1]
ENST00000374956; ENSP00000364094; ENSG00000150093. [P05556-3]
ENST00000396033; ENSP00000379350; ENSG00000150093. [P05556-1]
ENST00000423113; ENSP00000388694; ENSG00000150093. [P05556-5]
GeneIDi3688.
KEGGihsa:3688.
UCSCiuc001iwr.4. human. [P05556-5]
uc001iws.4. human. [P05556-1]

Polymorphism databases

DMDMi218563324.

Keywords - Coding sequence diversityi

Alternative splicing

Cross-referencesi

Web resourcesi

Wikipedia

CD29 entry

Sequence databases

Select the link destinations:
EMBL
GenBank
DDBJ
Links Updated
X07979 mRNA. Translation: CAA30790.1 .
AK291697 mRNA. Translation: BAF84386.1 .
BX537407 mRNA. Translation: CAD97649.1 . Different initiation.
AL365203 Genomic DNA. Translation: CAI14426.1 .
CH471072 Genomic DNA. Translation: EAW85948.1 .
CH471072 Genomic DNA. Translation: EAW85949.1 .
CH471072 Genomic DNA. Translation: EAW85950.1 .
CH471072 Genomic DNA. Translation: EAW85951.1 .
CH471072 Genomic DNA. Translation: EAW85952.1 .
CH471072 Genomic DNA. Translation: EAW85953.1 .
CH471072 Genomic DNA. Translation: EAW85954.1 .
CH471072 Genomic DNA. Translation: EAW85955.1 .
CH471072 Genomic DNA. Translation: EAW85957.1 .
CH471072 Genomic DNA. Translation: EAW85958.1 .
CH471072 Genomic DNA. Translation: EAW85959.1 .
BC020057 mRNA. Translation: AAH20057.1 .
BC113901 mRNA. Translation: AAI13902.1 .
U33879 Genomic DNA. Translation: AAA79832.1 .
U33880 , U33879 Genomic DNA. Translation: AAA79833.1 .
U33882 , U33879 , U33881 Genomic DNA. Translation: AAA79834.1 .
U33882 , U33879 Genomic DNA. Translation: AAA79835.1 .
M34189 mRNA. Translation: AAA59182.1 .
M84237 mRNA. Translation: AAA74402.1 .
M84237 mRNA. Translation: AAA74403.1 .
U28252 mRNA. Translation: AAA81366.1 .
CCDSi CCDS7174.1. [P05556-1 ]
PIRi B27079.
RefSeqi NP_002202.2. NM_002211.3. [P05556-1 ]
NP_391988.1. NM_033668.2. [P05556-5 ]
NP_596867.1. NM_133376.2. [P05556-1 ]
XP_005252505.1. XM_005252448.1. [P05556-5 ]
UniGenei Hs.643813.

3D structure databases

Select the link destinations:
PDBe
RCSB PDB
PDBj
Links Updated
Entry Method Resolution (Å) Chain Positions PDBsum
1K11 model - B 786-797 [» ]
1LHA model - A 86-543 [» ]
3G9W X-ray 2.16 C/D 752-785 [» ]
3T9K X-ray 2.30 A/B 758-769 [» ]
3VI3 X-ray 2.90 B/D 21-465 [» ]
3VI4 X-ray 2.90 B/D 21-465 [» ]
4DX9 X-ray 3.00 6/7/8/9/B/D/F/H/J/L/N/P/R/T/V/X/Z/b/d/f/h/j/l/n/p/r/t/v/x/z 784-798 [» ]
ProteinModelPortali P05556.
SMRi P05556. Positions 25-787.
ModBasei Search...
MobiDBi Search...

Protein-protein interaction databases

BioGridi 109894. 65 interactions.
DIPi DIP-312N.
IntActi P05556. 39 interactions.
MINTi MINT-140089.

Chemistry

BindingDBi P05556.
ChEMBLi CHEMBL2095226.

PTM databases

PhosphoSitei P05556.

Polymorphism databases

DMDMi 218563324.

Proteomic databases

MaxQBi P05556.
PaxDbi P05556.
PRIDEi P05556.

Protocols and materials databases

DNASUi 3688.
Structural Biology Knowledgebase Search...

Genome annotation databases

Ensembli ENST00000302278 ; ENSP00000303351 ; ENSG00000150093 . [P05556-1 ]
ENST00000374956 ; ENSP00000364094 ; ENSG00000150093 . [P05556-3 ]
ENST00000396033 ; ENSP00000379350 ; ENSG00000150093 . [P05556-1 ]
ENST00000423113 ; ENSP00000388694 ; ENSG00000150093 . [P05556-5 ]
GeneIDi 3688.
KEGGi hsa:3688.
UCSCi uc001iwr.4. human. [P05556-5 ]
uc001iws.4. human. [P05556-1 ]

Organism-specific databases

CTDi 3688.
GeneCardsi GC10M033189.
HGNCi HGNC:6153. ITGB1.
HPAi CAB003434.
MIMi 135630. gene.
neXtProti NX_P05556.
PharmGKBi PA29953.
GenAtlasi Search...

Phylogenomic databases

eggNOGi NOG287997.
HOVERGENi HBG006190.
KOi K05719.
OMAi ENNVYTM.
OrthoDBi EOG7T7GSB.
PhylomeDBi P05556.
TreeFami TF105392.

Enzyme and pathway databases

Reactomei REACT_11152. Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
REACT_12051. Cell surface interactions at the vascular wall.
REACT_1230. Platelet Adhesion to exposed collagen.
REACT_12560. Basigin interactions.
REACT_13552. Integrin cell surface interactions.
REACT_150331. Molecules associated with elastic fibres.
REACT_150366. Elastic fibre formation.
REACT_160131. Fibronectin matrix formation.
REACT_163906. ECM proteoglycans.
REACT_163942. Syndecan interactions.
REACT_169262. Laminin interactions.
REACT_19200. Other semaphorin interactions.
REACT_20617. Localization of the PINCH-ILK-PARVIN complex to focal adhesions.
REACT_22272. Signal transduction by L1.
REACT_22292. CHL1 interactions.
SABIO-RK P05556.
SignaLinki P05556.

Miscellaneous databases

ChiTaRSi ITGB1. human.
EvolutionaryTracei P05556.
GeneWikii CD29.
GenomeRNAii 3688.
NextBioi 14435.
PMAP-CutDB Q8WUM6.
PROi P05556.
SOURCEi Search...

Gene expression databases

ArrayExpressi P05556.
Bgeei P05556.
Genevestigatori P05556.

Family and domain databases

Gene3Di 1.20.5.630. 1 hit.
3.40.50.410. 1 hit.
InterProi IPR013111. EGF_extracell.
IPR027071. Integrin_beta-1.
IPR015812. Integrin_bsu.
IPR014836. Integrin_bsu_cyt_dom.
IPR002369. Integrin_bsu_N.
IPR012896. Integrin_bsu_tail.
IPR016201. Plexin-like_fold.
IPR002035. VWF_A.
[Graphical view ]
PANTHERi PTHR10082. PTHR10082. 1 hit.
PTHR10082:SF28. PTHR10082:SF28. 1 hit.
Pfami PF07974. EGF_2. 1 hit.
PF08725. Integrin_b_cyt. 1 hit.
PF07965. Integrin_B_tail. 1 hit.
PF00362. Integrin_beta. 1 hit.
[Graphical view ]
PIRSFi PIRSF002512. Integrin_B. 1 hit.
PRINTSi PR01186. INTEGRINB.
SMARTi SM00187. INB. 1 hit.
SM00423. PSI. 1 hit.
SM00327. VWA. 1 hit.
[Graphical view ]
SUPFAMi SSF103575. SSF103575. 1 hit.
SSF53300. SSF53300. 1 hit.
SSF69687. SSF69687. 1 hit.
PROSITEi PS00022. EGF_1. 2 hits.
PS00243. INTEGRIN_BETA. 3 hits.
[Graphical view ]
ProtoNeti Search...

Publicationsi

« Hide 'large scale' publications
  1. Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
    Tissue: Placenta.
  2. "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
    Tissue: Placenta.
  3. Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
    Tissue: Endometrium.
  4. "The DNA sequence and comparative analysis of human chromosome 10."
    Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J.
    , Bird C.P., Ainscough R., Almeida J.P., Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.
    Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  5. Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  6. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
    Tissue: Skin.
  7. "Expression and functional analysis of a cytoplasmic domain variant of the beta 1 integrin subunit."
    Balzac F., Belkin A.M., Koteliansky V.E., Balabanov Y.V., Altruda F., Silengo L., Tarone G.
    J. Cell Biol. 121:171-178(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 717-757, CHARACTERIZATION OF BETA-1B, SUBCELLULAR LOCATION, TISSUE SPECIFICITY.
  8. "Expression of beta 1B integrin isoform in CHO cells results in a dominant negative effect on cell adhesion and motility."
    Balzac F., Retta S.F., Albini A., Melchiorri A., Koteliansky V.E., Geuna M., Silengo L., Tarone G.
    J. Cell Biol. 127:557-565(1994) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 717-757, FUNCTION.
  9. "A human integrin beta 1 subunit with a unique cytoplasmic domain generated by alternative mRNA processing."
    Altruda F., Cervella P., Tarone G., Botta C., Balzac F., Stefanuto G., Silengo L.
    Gene 95:261-266(1990) [PubMed] [Europe PMC] [Abstract]
    Cited for: PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY.
    Tissue: Skeletal muscle.
  10. "An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain."
    Languino L.R., Ruoslahti E.
    J. Biol. Chem. 267:7116-7120(1992) [PubMed] [Europe PMC] [Abstract]
    Cited for: PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), SUBCELLULAR LOCATION, TISSUE SPECIFICITY.
    Tissue: Cervix carcinoma.
  11. "Novel isoform of beta 1 integrin expressed in skeletal and cardiac muscle."
    Zhidkova N.I., Belkin A.M., Mayne R.
    Biochem. Biophys. Res. Commun. 214:279-285(1995) [PubMed] [Europe PMC] [Abstract]
    Cited for: PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY.
    Tissue: Skeletal muscle.
  12. "A novel beta 1 integrin isoform produced by alternative splicing: unique expression in cardiac and skeletal muscle."
    van der Flier A., Kuikman I., Baudoin C., van der Neut R., Sonnenberg A.
    FEBS Lett. 369:340-344(1995) [PubMed] [Europe PMC] [Abstract]
    Cited for: PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), TISSUE SPECIFICITY.
  13. "Identification of beta1C-2, a novel variant of the integrin beta1 subunit generated by utilization of an alternative splice acceptor site in exon C."
    Svineng G., Faessler R., Johansson S.
    Biochem. J. 330:1255-1263(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 4), TISSUE SPECIFICITY.
  14. "Interaction of ACE2 and integrin beta1 in failing human heart."
    Lin Q., Keller R.S., Weaver B., Zisman L.S.
    Biochim. Biophys. Acta 1689:175-178(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: PROTEIN SEQUENCE OF 775-784 (ISOFORM 5), IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH ACE2.
  15. "Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2."
    Bergelson J.M., St John N., Kawaguchi S., Chan M., Stubdal H., Modlin J., Finberg R.W.
    J. Virol. 67:6847-6852(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH HUMAN ECHOVIRUS 1 AND HUMAN ECHOVIRUS 8 CAPSID PROTEINS.
  16. "Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells."
    Belkin A.M., Zhidkova N.I., Balzac F., Altruda F., Tomatis D., Maier A., Tarone G., Koteliansky V.E., Burridge K.
    J. Cell Biol. 132:211-226(1996) [PubMed] [Europe PMC] [Abstract]
    Cited for: SUBCELLULAR LOCATION.
  17. "Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin."
    Sasaki T., Brakebusch C., Engel J., Timpl R.
    EMBO J. 17:1606-1613(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH LGALS3BP.
  18. "The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor."
    Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S., Manzari V., Modesti A., Nair B.C., Cafaro A., Stuerzl M., Ensoli B.
    Blood 94:663-672(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH HIV-1 TAT.
  19. "A novel muscle-specific beta 1 integrin binding protein (MIBP) that modulates myogenic differentiation."
    Li J., Mayne R., Wu C.
    J. Cell Biol. 147:1391-1398(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH NMRK2.
    Tissue: Heart.
  20. "Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation."
    Zhang J., Clatterbuck R.E., Rigamonti D., Chang D.D., Dietz H.C.
    Hum. Mol. Genet. 10:2953-2960(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH ITGB1BP1.
  21. "Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement."
    Fournier H.N., Dupe-Manet S., Bouvard D., Lacombe M.L., Marie C., Block M.R., Albiges-Rizo C.
    J. Biol. Chem. 277:20895-20902(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: SUBCELLULAR LOCATION.
  22. "Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin (beta) subunits."
    van Der Flier A., Kuikman I., Kramer D., Geerts D., Kreft M., Takafuta T., Shapiro S.S., Sonnenberg A.
    J. Cell Biol. 156:361-376(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH FLNA AND FLNB, MUTAGENESIS OF GLY-778 AND ALA-786.
  23. "The integrin cytoplasmic domain-associated protein ICAP-1 binds and regulates Rho family GTPases during cell spreading."
    Degani S., Balzac F., Brancaccio M., Guazzone S., Retta S.F., Silengo L., Eva A., Tarone G.
    J. Cell Biol. 156:377-387(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH ITGB1BP1, MUTAGENESIS OF 786-ALA--VAL-791.
  24. "Disruption of focal adhesions by integrin cytoplasmic domain-associated protein-1 alpha."
    Bouvard D., Vignoud L., Dupe-Manet S., Abed N., Fournier H.N., Vincent-Monegat C., Retta S.F., Fassler R., Block M.R.
    J. Biol. Chem. 278:6567-6574(2003) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH ITGB1BP1.
  25. "RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1."
    Denti S., Sirri A., Cheli A., Rogge L., Innamorati G., Putignano S., Fabbri M., Pardi R., Bianchi E.
    J. Biol. Chem. 279:13027-13034(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH RANBP9.
  26. "NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin."
    Fukushi J., Makagiansar I.T., Stallcup W.B.
    Mol. Biol. Cell 15:3580-3590(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH ITGA3; LGALS3 AND CSPG4.
  27. "Myosin-X provides a motor-based link between integrins and the cytoskeleton."
    Zhang H., Berg J.S., Li Z., Wang Y., Lang P., Sousa A.D., Bhaskar A., Cheney R.E., Stromblad S.
    Nat. Cell Biol. 6:523-531(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH MYO10.
  28. "Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration."
    Li J., Ballif B.A., Powelka A.M., Dai J., Gygi S.P., Hsu V.W.
    Dev. Cell 9:663-673(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH ACAP1, SUBCELLULAR LOCATION.
  29. "The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins."
    Gontier Y., Taivainen A., Fontao L., Sonnenberg A., van der Flier A., Carpen O., Faulkner G., Borradori L.
    J. Cell Sci. 118:3739-3749(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH FLNB AND FLNC.
  30. "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."
    Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D.
    J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-406.
    Tissue: Plasma.
  31. "Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins."
    Pellinen T., Arjonen A., Vuoriluoto K., Kallio K., Fransen J.A.M., Ivaska J.
    J. Cell Biol. 173:767-780(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH RAB21.
  32. Cited for: SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
    Tissue: Melanoma.
  33. "Interaction of integrin beta1 with cytokeratin 1 in neuroblastoma NMB7 cells."
    Chuang N.N., Huang C.C.
    Biochem. Soc. Trans. 35:1292-1294(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH KRT1, SUBCELLULAR LOCATION.
  34. "Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments."
    Caswell P.T., Spence H.J., Parsons M., White D.P., Clark K., Cheng K.W., Mills G.B., Humphries M.J., Messent A.J., Anderson K.I., McCaffrey M.W., Ozanne B.W., Norman J.C.
    Dev. Cell 13:496-510(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH RAB25.
  35. Cited for: FUNCTION, SUBCELLULAR LOCATION.
  36. "JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation."
    Luissint A.C., Lutz P.G., Calderwood D.A., Couraud P.O., Bourdoulous S.
    J. Cell Biol. 183:1159-1173(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN LEUKOCYTE TO ENDOTHELIAL CELLS ADHESION, INTERACTION WITH AMICA1.
  37. "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
    Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.
    J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-212; ASN-481 AND ASN-669.
    Tissue: Liver.
  38. "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."
    Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D.
    Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-403; ASN-406 AND ASN-411.
    Tissue: Leukemic T-cell.
  39. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
    Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
    Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-777, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Leukemic T-cell.
  40. "Lysine acetylation targets protein complexes and co-regulates major cellular functions."
    Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M.
    Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-794, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  41. "The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry."
    Feire A.L., Roy R.M., Manley K., Compton T.
    J. Virol. 84:10026-10037(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH HHV-5 GB.
  42. Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  43. "ACAP4 protein cooperates with Grb2 protein to orchestrate epidermal growth factor-stimulated integrin beta1 recycling in cell migration."
    Yu X., Wang F., Liu H., Adams G., Aikhionbare F., Liu D., Cao X., Fan L., Hu G., Chen Y., Frost A., Partridge E., Ding X., Yao X.
    J. Biol. Chem. 286:43735-43747(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH ASAP3.
  44. "Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition."
    Brunner M., Millon-Fremillon A., Chevalier G., Nakchbandi I.A., Mosher D., Block M.R., Albiges-Rizo C., Bouvard D.
    J. Cell Biol. 194:307-322(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH FERMT2 AND TLN1, MUTAGENESIS OF VAL-787.
  45. "Kindlin-2 regulates podocyte adhesion and fibronectin matrix deposition through interactions with phosphoinositides and integrins."
    Qu H., Tu Y., Shi X., Larjava H., Saleem M.A., Shattil S.J., Fukuda K., Qin J., Kretzler M., Wu C.
    J. Cell Sci. 124:879-891(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH FERMT2.
  46. "Mechanistic insights into regulated cargo binding by ACAP1 protein."
    Bai M., Pang X., Lou J., Zhou Q., Zhang K., Ma J., Li J., Sun F., Hsu V.W.
    J. Biol. Chem. 287:28675-28685(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 758-769 IN COMPLEX WITH ACAP1, INTERACTION WITH ACAP1 AND ITGA5, SUBCELLULAR LOCATION, MUTAGENESIS OF 760-ARG-ARG-761; 762-GLU--PHE-767 AND 768-LYS-GLU-769.
  47. "Crystal structure of alpha5beta1 integrin ectodomain: atomic details of the fibronectin receptor."
    Nagae M., Re S., Mihara E., Nogi T., Sugita Y., Takagi J.
    J. Cell Biol. 197:131-140(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 21-465 IN COMPLEX WITH ANTIBODY; ITGA5 AND RGD PEPTIDE, DISULFIDE BONDS, GLYCOSYLATION AT ASN-269 AND ASN-406, METAL-BINDING SITES, SUBUNIT.
  48. "Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation."
    Liu W., Draheim K.M., Zhang R., Calderwood D.A., Boggon T.J.
    Mol. Cell 49:719-729(2013)
    Cited for: X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 784-798 IN COMPLEX WITH ITGB1BP1, INTERACTION WITH ITGB1BP1, MUTAGENESIS OF THR-788; VAL-790; ASN-792 AND TYR-795.

Entry informationi

Entry nameiITB1_HUMAN
AccessioniPrimary (citable) accession number: P05556
Secondary accession number(s): A8K6N2
, D3DRX9, D3DRY3, D3DRY4, D3DRY5, P78466, P78467, Q13089, Q13090, Q13091, Q13212, Q14622, Q14647, Q29RW2, Q7Z3V1, Q8WUM6
Entry historyi
Integrated into UniProtKB/Swiss-Prot: November 1, 1988
Last sequence update: December 16, 2008
Last modified: September 3, 2014
This is version 185 of the entry and version 2 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Keywords - Technical termi

3D-structure, Complete proteome, Direct protein sequencing, Reference proteome

Documents

  1. Human cell differentiation molecules
    CD nomenclature of surface proteins of human leucocytes and list of entries
  2. Human chromosome 10
    Human chromosome 10: entries, gene names and cross-references to MIM
  3. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  4. PDB cross-references
    Index of Protein Data Bank (PDB) cross-references
  5. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3

Similar proteinsi